Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silodosin and tamsulosin for symptomatic lower ureteral stones larger than 5 mm
ACTRN12611000571976Phase 4Recruiting
- Sponsor
- Chung Jing Wang
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of silodosin and tamsulosin in ureterolithiasis, sponsored by Chung Jing Wang. Primary endpoints: expulsion time and expulsion rate. Started Oct 2010; status: recruiting.
02
Drugs
silodosintamsulosin
03
Conditions
ureterolithiasis
Beyond the preview
Go deeper on ACTRN12611000571976.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000571976.